Improving outcomes in patients with type 2 diabetes mellitus: practical solutions for clinical challenges
- PMID: 20554501
Improving outcomes in patients with type 2 diabetes mellitus: practical solutions for clinical challenges
Abstract
The incidence and prevalence of type 2 diabetes mellitus (T2DM) in the United States continue to rise, and the disease has become an enormous health concern. While effective glycemic management reduces the risk of diabetes-related complications in patients with T2DM, many patients are unable to reduce their glucose levels to target goals. The authors review key elements in the management of T2DM with an emphasis on achieving and maintaining glycemic control. Strategies are offered to provide practical solutions to the challenges faced by healthcare providers and patients with T2DM. The importance of implementing evidence-based practice guidelines while empowering patients to participate in self-management of their disease is highlighted.
Similar articles
-
Control of postprandial glucose levels with insulin in type 2 diabetes.Postgrad Med. 2011 Jul;123(4):135-47. doi: 10.3810/pgm.2011.07.2313. Postgrad Med. 2011. PMID: 21680998 Review.
-
Type 2 diabetes mellitus: managing hemoglobin A(1c) and beyond.South Med J. 2010 Sep;103(9):911-6. doi: 10.1097/SMJ.0b013e3181eb34b2. South Med J. 2010. PMID: 20689486 Review.
-
[Towards personalized treatment of type 2 diabetes].Ned Tijdschr Geneeskd. 2019 Jan 14;163:D3494. Ned Tijdschr Geneeskd. 2019. PMID: 30676703 Dutch.
-
Optimizing Insulin Therapy: Basal Insulin and Beyond.J Fam Pract. 2018 Oct;67(10 Suppl):jfp_6710r. J Fam Pract. 2018. PMID: 30423012
-
Risks and benefits of attaining HbA(1c) goals: examining the evidence.J Am Osteopath Assoc. 2010 Jul;110(7 Suppl 7):eS7-12. J Am Osteopath Assoc. 2010. PMID: 20644204 Review.
Cited by
-
Apolipoprotein E Gene Variation in Pakistani Subjects with Type 2 Diabetes with and without Cardiovascular Complications.Medicina (Kaunas). 2024 Jun 10;60(6):961. doi: 10.3390/medicina60060961. Medicina (Kaunas). 2024. PMID: 38929578 Free PMC article.
-
High atherogenic risk concomitant with elevated HbA1c among persons with type 2 diabetes mellitus in North Ethiopia.PLoS One. 2022 Feb 1;17(2):e0262610. doi: 10.1371/journal.pone.0262610. eCollection 2022. PLoS One. 2022. PMID: 35104300 Free PMC article.
-
Brain GLP-1/IGF-1 Signaling and Autophagy Mediate Exendin-4 Protection Against Apoptosis in Type 2 Diabetic Rats.Mol Neurobiol. 2018 May;55(5):4030-4050. doi: 10.1007/s12035-017-0622-3. Epub 2017 Jun 2. Mol Neurobiol. 2018. PMID: 28573460
-
Insulin as a Bridge between Type 2 Diabetes and Alzheimer Disease - How Anti-Diabetics Could be a Solution for Dementia.Front Endocrinol (Lausanne). 2014 Jul 8;5:110. doi: 10.3389/fendo.2014.00110. eCollection 2014. Front Endocrinol (Lausanne). 2014. PMID: 25071725 Free PMC article. Review.
-
New views and possibilities of antidiabetic drugs in treating and/or preventing mild cognitive impairment and Alzheimer's Disease.Metab Brain Dis. 2018 Aug;33(4):1009-1018. doi: 10.1007/s11011-018-0227-1. Epub 2018 Apr 6. Metab Brain Dis. 2018. PMID: 29626315 Review.